The contractor shall to evaluate the different CO-delivery methods of a model HIV antigen using the vesivax liposomal platform.
Ended Definitive Contract Awarded Last action
- Contract number
- 75N93021C00027
- Awardee
-
Molecular Express, Inc. UEI R1JMHFESEKD5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,294,565
Award facts
- Opportunity
-
- A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proprosals Pre-Solicitation · SBIRPHS20211 · Posted Jul 9, 2020
- Development of a VesiVax® HIV Vaccine Formulation Award Notice · Posted Jul 2, 2021
- Contract value 100% obligated
- $2,294,565.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 4 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Rancho Dominguez, Compton, CA, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $1,994,571 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $299,994 |
About this award
Molecular Express Inc. was awarded a $2.3 million definitive contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to evaluate different co-delivery methods of a model HIV antigen using the Vesivax liposomal platform. This contract was awarded under a Small Business Innovation Research solicitation issued jointly by NIH and the Centers for Disease Control and Prevention seeking proposals aligned with agency missions through innovative solutions in areas including infectious diseases. The work will be performed in Rancho Dominguez, California over a three year period from July 2021 through July 2024 under a firm fixed price arrangement. This opportunity was set aside solely for total small business participation.
Quick answers
Who was awarded contract 75N93021C00027?
75N93021C00027 was awarded to Molecular Express, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 1, 2021.
How much is contract 75N93021C00027 worth?
The government has obligated $2,294,565 on 75N93021C00027.
Was contract 75N93021C00027 competed?
The extent of competition for 75N93021C00027 was full and open competition after exclusion of sources. The government received 4 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award